Skip to main content

Dermatology CRO Excellence, Tailored To You

Harnessing 25+ Years of Expertise with Unrivaled Agility, Our Collaborative Dermatology Specialists Are Dedicated to the Success of Your Trial.

Request a Proposal

Our Dermatology CRO Team

Shaping the Future of Phase I-IV Dermatological Research

Ina Zschocke

VP, Head of Dermatology, Immunology, & Inflammatory Diseases

Elvira Szijártó

Medical Director, Dermatology

Maciej Borkowski

Associate Director, Project Management

Laurel Neal

Senior Director, Project Management, Dermatology

Our Dermatology CRO Services

At the Forefront of Dermatologic Drug Development and Research

At TFS HealthScience, our legacy is defined by over 25 years of unwavering commitment to clinical research.

Positioned as a global mid-size CRO, we seamlessly integrate the agility and adaptability of smaller organizations with the comprehensive capabilities and robust global footprint of a mid-size CRO. This balanced approach allows us to navigate the challenging clinical trial landscape with unmatched efficiency.

Many customers originally chose TFS based on our renowned reputation for dermatologically experienced resources and our impeccable delivery of high-quality clinical development services. They’ve since become loyal partners, not just because of our expertise, but because we genuinely listen. Every project we undertake echoes our commitment to deliver timely, budget-aligned solutions that cater precisely to our customer’s unique requirements

Having carved out a niche in dermatology phase I-IV research, our expertise spans a spectrum from skin disorder clinical trials and cosmetic dermatology research to cutting-edge transdermal drug trials and all types of dermatologic drug development.

Whether it’s managing complex eczema clinical studies or pioneering new avenues in dermatologic biometrics, our proficiency is unmatched across diverse indications. At every step, we prioritize close collaboration with our partners, sculpting regulatory and operational strategies that are meticulously tailored to each trial’s distinctive requirements. Our unwavering commitment is to transcend the conventional, delivering both the scientific and medical facets of your clinical program to position it for market leadership.

Yet, the heartbeat of TFS HealthScience lies in its people.

Our team, fueled by passion and purpose, resonates deeply with the aspirations and needs of patients suffering from skin conditions worldwide. With their dedication, alongside an extensive global network of key opinion leaders (KOLs), we offer unrivaled support in site start-up, patient access, referral, recruitment, and retention. Moreover, our expertise in investigator identification ensures we operate seamlessly, whether on a global scale or tailored to regional and local nuances. It’s this synergy of expertise, adaptability, and human touch that elevates TFS HealthScience in the realm of dermatology and beyond.

Our Dermatology CRO Impact

Trusted Science, Quality and Passion in the Numbers

>250 dermatology studies

20+ countries

>6,000 sites

60,000+ patients

Our Dermatology CRO Expertise

Comprehensive Clinical Trial Execution Across Multiple Indications and Phases

  • Acne
  • Actinic keratosis
  • Atopic dermatitis
  • Allergic Rhinitis (Rheumatology & Allergy Indications)
  • Allergies (Rheumatology & Allergy Indications)
  • Basel cell carcinoma
  • Baldness/hair loss (Aesthetic Indications)
  • Blisters
  • Bruns (Wound Indications)
  • Canthal lines (Aesthetic Indications)
  • Cellulite/fat reduction (Aesthetic Indications)
  • Chronic inflammation (Rheumatology & Allergy Indications)
  • Chronic wounds (Wound Indications)
  • Collagen (Aesthetic Indications)
  • Diabetic foot ulcer (Wound Indications)
  • Eczema
  • Epidermolysis bullosa
  • Facial volume loss (Aesthetic Indications)
  • Folliculitis
  • Glabella lines (Aesthetic Indications)
  • Hemangioma
  • Hidradenitis suppurativa
  • Lupus (Rheumatology & Allergy Indications)
  • Melanoma
  • Onychomycosis
  • Osteoarthritis (Rheumatology & Allergy Indications)
  • Pruritus
  • Psoriatic Arthritis (Rheumatology & Allergy Indications)
  • Psoriasis
  • Rheumatoid Arthritis (Rheumatology & Allergy Indications)
  • Rosacea
  • Scarring (Wound Indications)
  • Scleroderma (Rheumatology & Allergy Indications)
  • Seborrhea
  • Skin infections
  • Skin rejuvenation (Aesthetic Indications)
  • Sweat gland disorders
  • Utricaria
  • Warts
  • Wrinkles (Aesthetic Indications)
  • Wound care (Wound Indications)
  • Wound healing (Wound Indications)

Dermatology Events

Dermatology Insights


TFS Case Study
Case Study

Triumph Over Turbulence: TFS Helps Navigate the Stormy Seas of Recruitment and Safety

Discover how TFS’ expertise and experience delivered tailored solutions in a Phase IIIb study on Plaque Psoriasis in Adolescents.
TFS Case Study
Case Study

Overcoming Adversity: TFS Deploys Creative Solutions for a Challenging Phase I Study

Learn how TFS successfully navigated a complex Phase I study aimed at evaluating a novel therapy with the potential to strengthen existing antibiotic treatments for MTB.
TFS Rescues Phase III Onychomycosis Study
Case Study

Reviving Recruitment: TFS Rescues Phase III Onychomycosis Study

Discover the remarkable story of how TFS HealthScience managed to rescue a critical Phase III Onychomycosis study from failure.